BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS

Soverini, Simona, Martelli, Margherita, Bavaro, Luana · Leukemia · 2021